The former Novartis manufacturing facility in Ringaskiddy, Ireland is now officially owned by Sterling Pharma.

Ster­ling Phar­ma com­pletes ac­qui­si­tion of No­var­tis man­u­fac­tur­ing plant in Ire­land

The UK-based con­tract man­u­fac­tur­er Ster­ling Phar­ma So­lu­tions has com­plet­ed a pur­chase that will give it a man­u­fac­tur­ing pres­ence on the oth­er side of the Irish Sea.

Ster­ling closed its ac­qui­si­tion of an ac­tive phar­ma­ceu­ti­cal in­gre­di­ent (API) plant in the south­ern Irish vil­lage of Ringask­id­dy, Ire­land, that once be­longed to the Swiss phar­ma No­var­tis. The deal, an­nounced in March of last year, will not on­ly give the British CD­MO more ca­pac­i­ty to pro­duce APIs, but al­so in­cludes a sup­ply agree­ment with No­var­tis to con­tin­ue to pro­duce in­gre­di­ents for car­dio­vas­cu­lar, im­munol­o­gy and on­col­o­gy med­i­cines.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.